VANCOUVER, British Columbia, March 29, 2023 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental. | March 29, 2023
VANCOUVER, British Columbia - BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that. | December 5, 2022
VANCOUVER, British Columbia, June 21, 2022 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders,. | June 21, 2022
VANCOUVER, British Columbia, May 28, 2021 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“
BetterLife” or the “
Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ) is pleased to announce the closing of its bought-deal public offering pursuant to which the Company issued 15,812,500 units of the Company (the “
Units”) at a price of $0.40 per Unit for aggregate gross proceeds to the Company of $6,325,000 (the “
Offering”), including the full exercise of the over-allotment option. The Offering was led by Research Capital Corporation as the sole underwriter and sole bookrunner (the “
Underwriter”).
Common Share”) and one Common Share purchase warrant of the Company (a
Warrant ). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of $0.50 at any time up to 36 months from the closing of the Offering.